相关实验视频
Updated: May 25, 2025

15:43
Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
Published on: March 17, 2014
22.6K
[一个反IgLON5疾病病例与复发性呼吸衰竭]
Shintaro Akamatsu1, Heisuke Mizukami1, Akio Kimura2
1Department of Neurology, St. Marianna University School of Medicine.
Rinsho shinkeigaku = Clinical neurology
|February 26, 2025
概括
这项研究突出了抗免疫球蛋白样蛋白1细胞粘附分子5 (抗IgLON5) 疾病中呼吸衰竭的罕见原因:小结节下喉. 这一发现为管理患有这种神经疾病的患者提供了新的见解.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 呼吸系统医学 呼吸系统医学
背景情况:
- 帕金森病可以表现为复杂的神经症状.
- 抗免疫球蛋白样蛋白1细胞粘附分子5 (anti-IgLON5) 疾病是一种罕见的自身免疫性疾病.
- 呼吸衰竭是某些神经疾病的严重并发症.
研究的目的:
- 在患有帕金森病和抗IgLON5抗体的患者中调查复发性呼吸衰竭的原因.
- 为了确定在抗IgLON5疾病中呼吸道损害的潜在机制.
- 评估类固醇脉冲疗法在治疗呼吸困难方面的疗效.
主要方法:
- 一个72岁的妇女患有帕金森病和复发性低氧化血的病例报告.
- 诊断工作包括测量抗IgLON5抗体.
- 临床评估以排除声带和呼吸道肌肉疲弱.
- 用类固醇脉冲疗法进行治疗.
主要成果:
- 根据阳性抗体发现,该患者被诊断出患有抗IgLON5疾病.
- 呼吸衰竭并不能用声带或肌肉疲弱来解释.
- 下喉发作被假设为呼吸困扰的原因.
- 类固醇脉冲疗法导致通风改善.
结论:
- 抗IgLON5疾病可以表现为由于下喉 spasm 的呼吸衰竭.
- 这种机制提供了一个除了肌肉软弱之外的呼吸道损害的替代解释.
- 早期诊断和治疗,如使用类固醇,可以改善受影响患者的结果.
相关概念视频
Acute Respiratory Failure-II
158
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
158
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Acute Respiratory Failure-I
159
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
159
Acute Respiratory Failure-III
151
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
151
Chronic Obstructive Pulmonary Disease
1.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.1K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K

